Newsroom

Filters: 2017
x

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

Over 100 participants explored different ways and opportunities to ensure […]

Read more

Biosimilars at work: Access. Experience. Science.

1 April 2017

Biosimilar medicines are a part of today’s therapeutic armamentarium – […]

Read more

22nd EAHP Conference in Cannes

25 March 2017

A special satellite  symposium was organized on “Value added medicines […]

Read more

Biosimilar Medicines: a Game Changer for Oncology Care

23 March 2017

With 10 years of positive experience with biosimilar medicines, medical […]

Read more

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

Open

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

Key authorities, eminent lawyers and industry leaders discussed today in […]

Read more

Biosimilar interchangeability: Do you know your switching from your substitution?

21 March 2017

US FDA interchangeability guidance adds another level of confusion over […]

Read more

Some EU countries effectively delay market entry of generics

17 March 2017

The harmonisation of different regulatory environments in the EU member […]

Read more

European Experience and Evidence of Physician-led Switching of Biological Medicines Give Hope to Patients around the World

14 March 2017

On 9th March, IFPMA launched jointly with EFPIA and EBE […]

Read more

Experience and Evidence of Physician-led Switching of Biological Medicines Fully Recognised in Europe

9 March 2017

Medicines for Europe welcomes the fact that EFPIA (supported by […]

Read more

Subscribe to our newsletter